Daily Express - Don’t get ill: Doctors’ strike is going to hurt

Summary of the front page

The Daily Express says NHS leaders have warned patients will suffer as junior doctors strike for four days this week.

Dr Carter’s warning that the action is “going to hurt” leads the coverage, with the added detail that health and government officials are warning the public to avoid “risky behaviour”. 

There is also a large image of Princes William and Harry in military uniform, with the promise that a “sensational” new TV series will explain “why Harry went to war and not” his brother.

Today's top stories

1787191216 MOUNTED TROOP

Canadian military history showcased at Whoop-Up Days in Lethbridge

The Lord Strathcona’s Horse (Royal Canadians) showcased its cavalry heritage in Lethbridge this week during Whoop-Up Days, highlighting the regiment’s historical significance through various events and displays aimed at local residents and visitors.

gettyimages 2214317647

Woman alleges sexual assault by Rep. Jimmy Gomez to House Ethics Committee

Rep. Jimmy Gomez faces allegations of sexual assault from an unnamed woman before the House Ethics Committee, which is investigating claims of inappropriate contact with a staffer. Gomez contends the actions were consensual, but the woman’s attorneys refute this. House Democratic leaders have called for a thorough inquiry.

696x392 cmsv2 4c641815 33f9 51ec 9435 2014219d699a 9881191

Two men arrested in Nîmes over involvement in ongoing investigation

Two men were arrested on Wednesday in Nîmes and placed in police custody due to evidence indicating their direct or indirect involvement in recent events, according to public prosecutor Cécile Gensac. The investigation continues to unfold as authorities gather more information.

ap 6a8607ce7f892 1787168718

Moderna and Merck announce mRNA cancer vaccine Intismeran reduces melanoma spread

Moderna and Merck have reported promising results for their personalised mRNA cancer vaccine, Intismeran, which reduced melanoma recurrence and spread in late-stage trials. The interim findings support potential regulatory approval, with thousands of high-risk patients projected to benefit from the treatment next year.

Like this article?

Leave a comment

From our sponsors
Advertisement
Advertisement